InsidersTradesSigma
Discover the detailed record of transactions filed by Cory David A, 首席执行官. Director active across 1 company, notably Eiger BioPharmaceuticals, Inc.. Cumulatively, 1 reports have been recorded. History available since 11 March 2022. The latest transaction was filed on 11 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
David A. Cory is President and CEO of Eiger BioPharmaceuticals, Inc. He is responsible for the strategic direction of the company and the management of its daily operations. David plays a crucial role in defining Eiger's vision and goals while overseeing the execution of growth strategies.